Defects in NK cell immunity of pediatric cancer patients revealed by deep immune profiling

Area of Science:

• Immunology
• Pediatric Oncology
• Cancer Research

Background:

• Systemic immunity is crucial for cancer immune surveillance and treatment response.
• The immune status of children with solid tumors remains poorly understood.
• Understanding immune cell dysfunction in pediatric cancers is vital for developing effective therapies.

Purpose of the Study:

• To investigate the systemic immune status in treatment-naive pediatric cancer patients.
• To characterize the functional and phenotypic alterations of natural killer (NK) cells in pediatric cancer.
• To identify potential strategies for restoring NK cell function in pediatric cancer.

Main Methods:

• High-dimensional single-cell analysis of peripheral blood from 50 pediatric cancer patients and age-matched healthy children.
• Flow cytometry to assess NK cell frequency, receptor expression (activating and inhibitory), and maturation markers.
• In vitro cytotoxicity assays to evaluate NK cell function.
• Interleukin-2 (IL-2) stimulation to assess potential for functional restoration.

Main Results:

• Pediatric cancer patients showed a decreased frequency of peripheral NK cells compared to healthy controls.
• NK cells in cancer patients had reduced expression of activating receptors and increased expression of the inhibitory NKG2A receptor.
• NK cells from pediatric cancer patients exhibited decreased maturation and cytotoxic activity in vitro.
• IL-2 treatment successfully restored the cytotoxic function of these NK cells in vitro.

Conclusions:

• NK cells in pediatric cancer patients are impaired through multiple mechanisms, including reduced frequency, altered receptor expression, and decreased cytotoxicity.
• These findings highlight the compromised systemic immunity in pediatric cancer.
• Restoring NK cell function, potentially through cytokine-based therapies like IL-2, represents a promising therapeutic strategy for pediatric solid tumors.